Literature DB >> 25278009

Impact of feedback on physical activity levels of individuals with chronic obstructive pulmonary disease during pulmonary rehabilitation: A feasibility study.

Joana Cruz1, Dina Brooks2, Alda Marques3.   

Abstract

This study aimed at investigating whether providing feedback on physical activity (PA) levels to patients with chronic obstructive pulmonary disease (COPD) is feasible and enhances daily PA during pulmonary rehabilitation (PR). Patients with COPD participated in a 12-week PR program. Daily PA was measured using activity monitors on weeks 1, 7, and 12, and feedback was given in the following weeks on the number of steps, time spent in sedentary, light, and moderate-to-vigorous intensity activities, and time spent standing, sitting, and lying. Compliance with PA monitoring was collected. Two focus groups were conducted to obtain patients' perspectives on the use of activity monitors and on the feedback given. Differences in PA data were also assessed. Sixteen patients (65.63 ± 10.57 years; forced expiratory volume in one second (FEV1) 70.31 ± 22.74% predicted) completed the study. From those, only eleven participants used the activity monitors during all monitoring days. Participants identified several problems regarding the use of activity monitors and monitoring duration. Daily steps (p = 0.026) and standing time (p = 0.030) were improved from week 1 to week 7; however, the former declined from week 7 to week 12. Findings suggest that using feedback to improve PA during PR is feasible and results in improved daily steps and standing time on week 7. The subsequent decline suggests that additional strategies may be needed to stimulate/maintain PA improvements. Further research with more robust designs is needed to investigate the impact of feedback on patients' daily PA.
© The Author(s) 2014.

Entities:  

Keywords:  Accelerometer; chronic obstructive pulmonary disease; exercise; monitoring; physical activity; rehabilitation

Mesh:

Year:  2014        PMID: 25278009     DOI: 10.1177/1479972314552280

Source DB:  PubMed          Journal:  Chron Respir Dis        ISSN: 1479-9723            Impact factor:   2.444


  6 in total

1.  Measurement of daily physical activity using the SenseWear Armband: Compliance, comfort, adverse side effects and usability.

Authors:  Renae J McNamara; Ling Ling Y Tsai; Sally L Wootton; L W Cindy Ng; Marita T Dale; Zoe J McKeough; Jennifer A Alison
Journal:  Chron Respir Dis       Date:  2016-02-15       Impact factor: 2.444

2.  Walk2Bactive: A randomised controlled trial of a physical activity-focused behavioural intervention beyond pulmonary rehabilitation in chronic obstructive pulmonary disease.

Authors:  Joana Cruz; Dina Brooks; Alda Marques
Journal:  Chron Respir Dis       Date:  2015-12-23       Impact factor: 2.444

Review 3.  Exercise Training in Patients with Chronic Respiratory Diseases: Are Cardiovascular Comorbidities and Outcomes Taken into Account?-A Systematic Review.

Authors:  Ana Machado; Kirsten Quadflieg; Ana Oliveira; Charly Keytsman; Alda Marques; Dominique Hansen; Chris Burtin
Journal:  J Clin Med       Date:  2019-09-13       Impact factor: 4.241

4.  Using Smart Bracelets to Assess Heart Rate Among Students During Physical Education Lessons: Feasibility, Reliability, and Validity Study.

Authors:  Jiangang Sun; Yang Liu
Journal:  JMIR Mhealth Uhealth       Date:  2020-08-05       Impact factor: 4.773

Review 5.  Quantifying the Effect of Monitor Wear Time and Monitor Type on the Estimate of Sedentary Time in People with COPD: Systematic Review and Meta-Analysis.

Authors:  Fiona Coll; Vinicius Cavalheri; Daniel F Gucciardi; Sheldon Wulff; Kylie Hill
Journal:  J Clin Med       Date:  2022-04-01       Impact factor: 4.241

6.  A Mobile Phone App to Stimulate Daily Physical Activity in Patients with Chronic Obstructive Pulmonary Disease: Development, Feasibility, and Pilot Studies.

Authors:  Sigrid Nw Vorrink; Helianthe Sm Kort; Thierry Troosters; Jan-Willem J Lammers
Journal:  JMIR Mhealth Uhealth       Date:  2016-01-26       Impact factor: 4.773

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.